Depository Library Council Meeting, 26888 [2024-08040]
Download as PDF
26888
Federal Register / Vol. 89, No. 74 / Tuesday, April 16, 2024 / Notices
federal procurement of products that
either intentionally or unintentionally
contain PFAS while minimizing any
unnecessary burdens on our industry
and logistics partners.
khammond on DSKJM1Z7X2PROD with NOTICES
III. Request for Operational
Information
GSA seeks responses to the questions
listed below. Please explain the
reasoning behind your responses in
detail. Also, please provide any data,
studies, or other evidence that supports
your response.
In your response please include your
contact information, your business
socio-economic category if applicable,
and a little bit about your business (such
as if you represent a manufacturer,
distributor, reseller, or other).
To help GSA review comments
efficiently, identify the question to
which you are responding by its
associated number and letter (e.g.,
‘‘III.3a’’) or whether you are
commenting on a topic not listed below.
1. Aside from a product’s ecolabel, are
there other ways to identify if a product
contains PFAS?
2. Considering GSA’s goal to reduce
products containing PFAS, what
product categories have the greatest
opportunity for GSA to reduce or
eliminate PFAS exposure?
3. What should GSA consider in terms
of defining if a product has reduced or
eliminated PFAS?
4. What product areas should GSA
exclude at this time and why?
5. Are there unintended impacts GSA
should anticipate?
a. If so, what mitigation strategies
should GSA consider?
6. What is the potential impact on
domestic manufacturing if GSA
establishes PFAS reduction
requirements that reduce or prohibit
PFAS, or eliminate them entirely?
7. What limitations exist for you to
identify PFAS in the products that you
offer?
8. Would your answers to questions
#6 and #7 be different if only
intentionally added PFAS (or when a
PFAS containing chemical is included
in a product that serves an intended
function in the product) was the focus
of this inquiry?
9. What is the potential impact on
small businesses including socioeconomic small businesses if GSA
establishes PFAS reduction
requirements or prohibited PFAS
entirely?
10. How long should GSA give
contractors to reduce PFAS?
11. What type of exception process
should GSA consider?
VerDate Sep<11>2014
19:09 Apr 15, 2024
Jkt 262001
12. What information is readily
available for you to determine if your
products contain PFAS chemicals?
a. If there is not information readily
available, what type of tools would help
you determine if PFAS is present (e.g.,
supply chain mapping, specific
ecolabels, etc.)
13. Would it be more impactful for
GSA to target a specific product type or
chemical signature in products to meet
the goal of reducing or eliminating
PFAS?
14. Are there existing industry
manufacturing standards or oversight
that address PFAS reduction or
elimination?
will take place from 12:30 p.m. to 5:15
p.m. (EDT). The meetings will take
place online, and anyone can register to
attend at https://www.fdlp.gov/about/
events-and-conferences/2024depository-library-council-virtualmeeting. Closed captioning will also be
provided. The purpose is to discuss
matters affecting the Federal Depository
Library Program and its transition to a
digital program. All sessions are open to
the public.
DATES: May 2, 2024.
IV. Request for Economic Data and
Consumer Research
Aside from the questions listed above,
GSA also seeks to better understand the
bigger picture regarding what industry
changes are in fact feasible from an
economic perspective. GSA seeks
economic data and consumer research
to help increase its understanding of the
market. In your response please
consider some of the questions
highlighted below. You do not have to
answer all of these in your response.
The intent of the following are simply
things to consider.
1. What will the estimated costs be to
either reduce or eliminate PFAS within
your industry?
2. Is there a large price differential
between a product that contains PFAS
and an alternative product?
3. How would a reduction or
elimination of PFAS containing
products impact your company’s ability
to compete?
4. To what extent is your industry
already moving to better understand and
reduce the presence of PFAS in
products as a result of broader market
forces or policies being considered or
enacted by entities other than the
federal government?
BILLING CODE 1520–01–P
Jeffrey A. Koses,
Senior Procurement Executive, Office of
Governmentwide Policy, U.S. General
Services Administration.
[FR Doc. 2024–07927 Filed 4–15–24; 8:45 am]
BILLING CODE 6820–61–P
GOVERNMENT PUBLISHING OFFICE
Depository Library Council Meeting
AGENCY:
U.S. Government Publishing
Office.
ACTION:
Notice of meeting.
The Depository Library
Council (DLC) will meet virtually on
Thursday, May 2, 2024. The sessions
SUMMARY:
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
Hugh Nathanial Halpern,
Director, U.S. Government Publishing Office.
[FR Doc. 2024–08040 Filed 4–15–24; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Closed Meeting
Pursuant to 5 U.S.C. 1009(d), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, CDC, pursuant to Public Law
92–463. The grant applications and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
PAR 20–280, Cooperative Research
Agreements Related to the World Trade
Center Health Program (U01); RFA–OH–
24–002, Exploratory/Developmental
Grants on Lifestyle Medicine Research
Related to the World Trade Center
Health Program (R21); RFA–OH–24–003,
Exploratory/Developmental Grants
Related to the World Trade Center
Survivors (R21-No Applications with
Responders Accepted); and RFA–OH–
24–004, World Trade Center Health
Program Mentored Research Scientist
Career Development Award (K01).
Dates: May 28–30, 2024.
Times: 11 a.m.–6 p.m., EDT.
Place: Video-Assisted Meeting.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\16APN1.SGM
16APN1
Agencies
- GOVERNMENT PUBLISHING OFFICE
[Federal Register Volume 89, Number 74 (Tuesday, April 16, 2024)]
[Notices]
[Page 26888]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-08040]
=======================================================================
-----------------------------------------------------------------------
GOVERNMENT PUBLISHING OFFICE
Depository Library Council Meeting
AGENCY: U.S. Government Publishing Office.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: The Depository Library Council (DLC) will meet virtually on
Thursday, May 2, 2024. The sessions will take place from 12:30 p.m. to
5:15 p.m. (EDT). The meetings will take place online, and anyone can
register to attend at https://www.fdlp.gov/about/events-and-conferences/2024-depository-library-council-virtual-meeting. Closed
captioning will also be provided. The purpose is to discuss matters
affecting the Federal Depository Library Program and its transition to
a digital program. All sessions are open to the public.
DATES: May 2, 2024.
Hugh Nathanial Halpern,
Director, U.S. Government Publishing Office.
[FR Doc. 2024-08040 Filed 4-15-24; 8:45 am]
BILLING CODE 1520-01-P